| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |